( = 315 patients)
The remaining five high-alert medications were not administered during the study period: cyclosporine, phenytoin, amiodarone, vecuronium, and rocuronium
Analyzing each patient’s electronic documentation, we identified 20,150 pDDIs involving at least one HAM on the basis of our database search in UpToDate and drugs.com. We calculated a rate of 78.7 pDDIs per patient that involved at least one HAM (20,150 pDDI involving at least one HAM/256 patients receiving HAM). The 20,150 pDDIs resulted from 469 different drug pairs. Of these potentially interacting drug pairs, 14.3% (67/469) were administered on at least 2% of patient days. The frequency of the potentially interacting drug pairs and their classifications according to the databases is presented in Online Resource 3.
We observed at least one symptom after 14.0% (2830/20,150) of pDDIs, resulting in a total of 3203 observed symptoms affecting 56.3% (144/256) of patients receiving HAM (Table 4 ). While we observed one symptom after the administration of 87.7% (2482/2830) of those pDDIs, more than one symptom was observed after 12.3% (348/2830) of pDDIs.
Frequency of symptoms observed after potential drug–drug interactions involving high-alert medications
Symptom | Frequency of symptoms, | Frequency related to total of symptoms, % ( = 3203) | Frequency of patients affected by the respective symptom after a pDDI involving HAM, (%) ( = 256 patients receiving HAM) |
---|---|---|---|
Increased heart rate | 781 | 24.4 | 62 (24.2) |
Hyponatremia | 390 | 12.2 | 52 (20.3) |
Vomiting | 262 | 8.2 | 41 (16.0) |
Hypokalemia | 243 | 7.6 | 18 (7.0) |
Decreased blood pressure | 237 | 7.4 | 28 (10.9) |
Respiratory depression | 164 | 5.1 | 24 (9.4) |
Urinary retention | 137 | 4.3 | 29 (11.3) |
Hyperkalemia | 131 | 4.1 | 43 (16.8) |
Edema | 128 | 4.0 | 13 (5.1) |
Nausea | 119 | 3.7 | 24 (9.4) |
Agitation | 118 | 3.7 | 21 (8.2) |
Decreased diuresis | 112 | 3.5 | 23 (9.0) |
Decreased heart rate | 96 | 3.0 | 10 (3.9) |
Hypomagnesemia | 57 | 1.8 | 14 (5.5) |
Sweating | 46 | 1.4 | 9 (3.5) |
Hypocalcemia | 43 | 1.3 | 12 (4.7) |
Increased blood pressure | 43 | 1.3 | 12 (4.7) |
Fever | 19 | 0.6 | 12 (4.7) |
Dyspnea | 14 | 0.4 | 7 (2.7) |
Seizures | 14 | 0.4 | 5 (2.0) |
Constipation | 10 | 0.3 | 4 (1.6) |
Diarrhea | 9 | 0.3 | 2 (0.8) |
Dizziness | 8 | 0.2 | 3 (1.2) |
Abdominal pain | 5 | 0.2 | 3 (1.2) |
Sedation | 4 | 0.1 | 1 (0.4) |
Excessive diuresis | 3 | 0.1 | 2 (0.8) |
Hypercalcemia | 3 | 0.1 | 2 (0.8) |
Increased PTH | 3 | 0.1 | 1 (0.4) |
Exanthema | 2 | 0.1 | 2 (0.8) |
Tachypnea | 2 | 0.1 | 2 (0.8) |
HAM high-alert medication, pDDI potential drug–drug interaction, PTH parathyroid hormone
The most pDDIs after which we observed at least one symptom involved potassium salts (2.4%; 493/20,150), followed closely by digoxin (2.4%; 480/20,150) and fentanyl (2.4%; 476/20,150; Fig. Fig.2 2 ).
For each high-alert medication, the number of potential drug–drug interactions (total interactions: N = 20,150) is plotted against how often at least one symptom was observed after a potential drug–drug interaction involving the respective high-alert medication (total interactions followed by symptoms: N = 2830)
For 33.1% (1061/3203) of observed symptoms, the preconditions for the calculation of the OR were fulfilled (Table (Table5). 5 ). We found an increased OR for hyponatremia, hypokalemia, decreased blood pressure, increased heart rate, urinary retention, edema, sweating, and restlessness (each p ≤ 0.05; Table Table5). 5 ). Those eight specific symptoms accounted for 28.0% (897/3203) of all observed symptoms potentially related to DDI. These DDIs involved eight different drugs in eight different combinations. Of the eight drugs, 75% (6/8) were defined as HAM for pediatric patients: digoxin, fentanyl, midazolam, phenobarbital, potassium salts, and vancomycin. The remaining 25% (2/8) were diuretics not defined as HAM: furosemide and hydrochlorothiazide. The highest OR was found for decreased blood pressure observed after administration of the drug pair fentanyl and furosemide (OR 5.06; 95% CI 3.5–7.4; p < 0.001), followed by hypokalemia observed after administration of the drug pairs digoxin and furosemide (OR 4.16; 95% CI 3.1–5.6; p < 0.001) and digoxin and hydrochlorothiazide (OR 3.86; 95% CI 2.9–5.1; p < 0.001).
Drug–drug interactions involving high-alert medications and subsequent symptoms observed within 24 h after the administration of the respective drug–drug interaction
pDDI | Classification | Associated symptom | Patient days with/without pDDI and symptom, | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Drug 1 | Drug 2 | UpToDate | drugs.com | pDDI | Yes | Yes | No | No | Odds ratio [95% CI] | value | |
Symptom | Yes | No | Yes | No | |||||||
Potassium salts | Furosemide | B | n/a | Hyponatremia | 163 | 667 | 341 | 2617 | 1.88 [1.5; 2.3] | < 0.001* | |
Fentanyl | Furosemide | C | Moderate | Decreased blood pressure | 43 | 275 | 104 | 3366 | 5.06 [3.5; 7.4] | < 0.001* | |
Urinary retention | 86 | 232 | 541 | 2929 | 2.01 [1.5; 2.6] | < 0.001* | |||||
Increased heart rate | 76 | 242 | 521 | 2949 | 1.78 [1.3; 2.3] | < 0.001* | |||||
Vancomycin | Furosemide | n/a | Moderate | Edema | 83 | 150 | 490 | 3065 | 3.46 [2.6; 4.6] | < 0.001* | |
Decreased diuresis | 42 | 191 | 575 | 2980 | 1.14 [0.8; 1.6] | 0.459 | |||||
Vomiting | 36 | 197 | 502 | 3053 | 1.11 [0.8; 1.6] | 0.573 | |||||
Digoxin | Furosemide | n/a | Moderate | Hypokalemia | 89 | 134 | 523 | 3042 | 3.86 [2.9; 5.1] | < 0.001* | |
Nausea | 10 | 213 | 177 | 3388 | 0.90 [0.5; 1.7] | 0.748 | |||||
Increased heart rate | 35 | 188 | 562 | 3003 | 0.99 [0.7; 1.4] | 0.978 | |||||
Hypomagnesemia | 12 | 211 | 238 | 3327 | 0.80 [0.4; 1.4] | 0.451 | |||||
Digoxin | HCT | n/a | Moderate | Hypokalemia | 86 | 120 | 526 | 3056 | 4.16 [3.1; 5.6] | < 0.001* | |
Increased heart rate | 29 | 177 | 568 | 3014 | 0.87 [0.6; 1.3] | 0.496 | |||||
Fentanyl | Phenobarbital | D | Major | Restlessness | 80 | 59 | 961 | 2688 | 3.79 [2.7; 5.4] | < 0.001* | |
Sweating | 30 | 109 | 480 | 3169 | 1.82 [1.2; 2.8] | 0.005* | |||||
Potassium salts | HCT | B | n/a | Hyponatremia | 85 | 229 | 419 | 3055 | 2.71 [2.1; 3.5] | < 0.001* | |
Midazolam | HCT | n/a | Moderate | Decreased blood pressure | 20 | 168 | 127 | 3473 | 3.26 [2.0; 5.3] | < 0.001* | |
Increased heart rate | 56 | 132 | 541 | 3059 | 2.40 [1.7; 3.3] | < 0.001* |
For each drug combination and observed symptom, the frequencies of patient days on which the respective potential drug–drug interaction was or was not administered and whether the symptom was observed is shown. From those numbers, the odds ratios, 95% confidence intervals, and p -values were calculated using a univariate logistic regression
HCT hydrochlorothiazide, n/a not applicable (not listed in the respective database), pDDI potential drug–drug interaction
*Significant
a Categorized as high-alert medication for hospitalized pediatric patients according to Schilling et al. [ 6 ]
b Classification used in UpToDate: “D—Consider therapy modification; C—Monitor therapy; B—No action needed. Agents may interact with each other”
c Classification used in Drugs.com: “Major—Avoid combinations; Moderate—Usually avoid combination. Use it only under special circumstances; Minor—Take steps to circumvent the interaction risk and/or establish a monitoring plan”
According to the ISMP, HAMs carry a higher risk of patient harm compared with ordinary drugs [ 7 ]. Even when used as prescribed, they significantly increase the risk of drug-related problems [ 11 ]. In our study, 81% of critically ill children received at least one drug defined as HAM for pediatric patients by Schilling et al. [ 6 ]. Potassium salts, midazolam, and vancomycin were the HAMs most frequently administered. This is in line with a previous study in a pediatric emergency setting reporting that 91% of patients were prescribed at least one HAM, with potassium salts being the most frequently administered [ 12 ].
It is widely known that pDDIs are highly prevalent in PICUs. They are associated with various factors, such as a high number of administered drugs, a complex chronic condition, or an increased length of hospitalization [ 4 , 13 , 14 ]. Although previous studies determined pDDI as a cause of drug-related problems with HAM for pediatric patients, there is only limited knowledge about the frequency of pDDIs in pediatric intensive care [ 6 , 8 , 10 ]. In our study, we found more than 20,000 pDDIs involving HAM in 256 pediatric patients over the 1-year study period. A previous Brazilian study of adult intensive care patients reported 846 HAM-related pDDIs in 60 patients [ 15 ]. Compared with our research, the Brazilian study reported a considerably lower rate of HAM-related pDDIs per patient (79 versus 14). Part of this difference may be explained by the fact that pediatric patients requiring intensive care are more susceptible to drug–drug interactions [ 16 ]. However, it may also be related to the fact that the Brazilian study was performed on the basis of the database Micromedex 2.0 only [ 15 ]. Several studies recommended using at least two databases to determine pDDIs in daily routine [ 17 – 19 ] . Thus, we used the two databases, UpToDate and drugs.com, to avoid underestimating any potential risks. However, since the concordance between different databases is limited, comparing various studies can be challenging [ 20 , 21 ].
For 2830 pDDIs, we observed 3203 symptoms occurring after the administration of the potentially interacting drug pairs. More than one in four detected symptoms were eventually associated with a DDI. Those interaction-associated symptoms comprised eight specific symptoms, mainly hemodynamic alterations or electrolyte and fluid balance disturbances. These symptoms were frequently reported in previous pediatric intensive care studies [ 3 , 22 – 24 ]. The study presented here shows that DDI involving HAM should be considered a likely trigger for symptoms in addition to other factors, such as the underlying disease or non-drug treatments, such as surgeries. It can also be assumed that various factors contribute to the occurrence of a symptom. When identifying DDIs and following interaction-associated symptoms, we did not distinguish between different severity grades of DDI or symptoms, as the main aim of our study was to identify drug pairs that are frequently associated with symptoms that are considered clinically relevant by the responsible physicians and nurses. Physicians usually receive a considerable number of alerts when using a database-related interaction checker. This may quickly lead to over-alerting. Therefore, we aimed to provide physicians with a concise overview of clinically relevant DDIs that occur frequently in a PICU. Our findings could be implemented in commonly used database-related interaction checkers to draw physicians’ attention to drug pairs involving HAM that are potentially associated with an increased risk of adverse events.
We identified eight specific drug pairs composed of eight different drugs that may lead to an increased risk of interaction-associated symptoms. By calculating the OR for a DDI and a respective symptom, we took into account how often a symptom was observed on patient days when the interacting drug pair was administered compared with days when the respective drug pair was not administered. In particular, this should minimize the risk that certain combinations of DDI and symptoms are over- or underestimated. For the interaction of fentanyl and furosemide, we found the highest OR for the symptom of decreased blood pressure. Both drugs have been shown to belong to the top ten of the most frequently administered drugs and to be among the drugs most commonly involved in pDDIs in the pediatric intensive care setting [ 4 ]. In our study, DDI was associated with a potential fivefold increased risk of decreased blood pressure. The second highest OR, indicating a potential fourfold increased risk, was found for the interaction of digoxin with hydrochlorothiazide and the observed symptom of hypokalemia. Consequently, when the administration of drug pairs associated with a potentially increased risk of interaction-associated symptoms is unavoidable, patients should be closely monitored for potential symptoms.
Until now, few studies have dealt with interaction-associated symptoms in the pediatric intensive care setting [ 14 , 25 , 26 ]. One of those studies only focused on cytochrome P450-mediated drug–drug interactions [ 25 ]. Two other studies concentrated on symptoms on the basis of clinical monitoring and laboratory results, as we did in our research. Both studies also identified hemodynamic alterations and electrolyte and fluid balance disturbances as symptoms following DDIs. However, neither of those studies noted specific interactions that increased the risk of the detected symptoms [ 14 , 26 ]. Our study went one step further by revealing eight interacting drug pairs that may increase the risk of the identified interaction-associated symptoms in clinical practice. We found symptoms that are widely known to follow the respective DDI, such as the association of hyponatremia with the DDI of potassium salts and furosemide, or the increased risk for hypokalemia associated with the DDI of digoxin and furosemide. However, we also observed symptoms after a DDI that we did not expect. For example, we unexpectedly found that the DDI of fentanyl and furosemide was associated with a potential risk increase for urinary retention, or that the DDI of vancomycin and furosemide was associated with edema. Especially for symptoms that unexpectedly are observed after a specific DDI, other factors, such as the state of illness or a surgery that could also lead to the symptom, should be critically evaluated.
Some limitations have to be considered when interpreting our study results. First of all, the relevance of some drugs administered in our study can vary in different PICUs around the world. However, the 15 drugs defined as HAM that were in the focus of our study are used in many PICUs worldwide [ 4 , 27 – 31 ].
As recommended by previous studies [ 17 – 19 ], we used two databases to prevent failure to detect interactions that could lead to interaction-associated symptoms. However, we could not identify a database specializing in DDI for pediatrics. Previous studies did not find an age-related trend in the magnitude of DDIs, although it should be noted that there are insufficient data for children under 2 years of age [ 32 , 33 ]. In addition, extrapolating data from adults to children may over- or underestimate the severity of DDIs [ 34 ]. Additionally, as most databases are limited to the information on the interactions of two drugs, potential synergistic or antagonistic effects of combinations consisting of three or more drugs might be overlooked.
Furthermore, the allowed maximum time interval of 24 h between the administration of two drugs may be too long for an interaction for some drug pairs. According to a previous review by Bakker et al., the optimal time interval would consider the half-lives of interacting drugs [ 21 ]. However, due to the developmental variability of pharmacokinetics and pharmacodynamics in children, it is very challenging to determine standardized drug half-lives in the pediatric population [ 35 ]. In addition, the individual patients’ conditions, such as renal function, can also have significant influence on drugs’ half-lives [ 36 ]. In addition, a constant plasma concentration is aimed for with many drugs, which is why a longer-lasting interaction potential can be assumed, although the half-lives of the individual drugs are varying. To ensure a standardized approach for evaluating DDI, we established a 24-h time interval as described in the review by Bakker et al. if consideration of drug half-lives is not feasible [ 21 ]. This methodological approach might potentially increase the risk of overestimation.
The retrospective design is another limitation of this study, as using nurses’ and physicians’ daily documentation entails the risk of missing data. That could lead to information bias, as the documentation was not primarily compiled to answer research questions. Consequently, using the patient documentation as data basis may have an impact on the identification of symptoms themselves, and on the observed associations between interacting drugs pairs and subsequent symptoms. Furthermore, due to the retrospective design, we could not assess whether the physicians accepted certain expectable symptoms as an inevitable consequence of the chosen drug therapy because the patient’s state of health required the administration.
In addition, it should be kept in mind that the administration of a HAM alone and the underlying disease may also increase the risk of adverse events. However, we focused on acknowledged DDIs and interaction-associated symptoms reported in established databases. We endeavored to identify symptoms prone to being associated with a DDI by calculating ORs, as those interactions potentially contribute to evoking symptoms, or to prolonging or exacerbating existing symptoms. These drug combinations should therefore be given special consideration in the routine care of critically ill pediatric patients who are already at risk.
Our study sheds light on a topic about which knowledge is limited: symptoms associated with DDIs involving HAM. We showed that pDDIs involving HAM are very common in pediatric intensive care. More than one in four observed symptoms were associated with a DDI. These symptoms were mainly disturbances of electrolyte and fluid balance and hemodynamic alterations. Focusing on drug pairs with a potentially increased risk of triggering these symptoms, we identified eight specific drug pairs composed of eight different drugs. However, administration of these drug pairs may be unavoidable. In that case, patients should be carefully monitored for electrolyte and fluid balance disturbances and hemodynamic alterations, which were observed as the most frequent interaction-associated symptoms.
Below is the link to the electronic supplementary material.
We thank all the physicians and nurses in the participating PICU for their helpful collaboration.
Open Access funding enabled and organized by Projekt DEAL.
A. Bertsche reports grants from UCB Pharma GmbH and honoraria for speaking engagements from Biogen GmbH, Desitin Arzneimittel GmbH, Eisai GmbH, GW Pharma GmbH, Neuraxpharm GmbH, Shire/Takeda GmbH, UCB Pharma GmbH, and ViroPharma GmbH. The other authors declare they have no conflicts of interests.
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to ethical and privacy considerations to protect the confidentiality of patients.
The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the Medical Faculty, Leipzig University, Germany (127/19-ek). The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
As this was a retrospective study and data were collected from patient records without any influence on patients’ treatment, the ethics committee waived informed consent.
Not applicable.
Conceptualization: Lisa Marie Kiesel and Martina Patrizia Neininger; methodology: Lisa Marie Kiesel, Martina Patrizia Neininger, Astrid Bertsche, Thilo Bertsche, Manuela Siekmeyer, and Wieland Kiess; formal analysis: Lisa Marie Kiesel; investigation: Lisa Marie Kiesel and Martina Patrizia Neininger; writing—original draft preparation: Lisa Marie Kiesel and Martina Patrizia Neininger; writing—review and editing: Astrid Bertsche, Thilo Bertsche, Manuela Siekmeyer, and Wieland Kiess; supervision: Martina Patrizia Neininger; project administration: Lisa Marie Kiesel and Martina Patrizia Neininger. All authors read and approved the final version.
Objectives This cohort study reported descriptive statistics in athletes engaged in Summer and Winter Olympic sports who sustained a sport-related concussion (SRC) and assessed the impact of access to multidisciplinary care and injury modifiers on recovery.
Methods 133 athletes formed two subgroups treated in a Canadian sport institute medical clinic: earlier (≤7 days) and late (≥8 days) access. Descriptive sample characteristics were reported and unrestricted return to sport (RTS) was evaluated based on access groups as well as injury modifiers. Correlations were assessed between time to RTS, history of concussions, the number of specialist consults and initial symptoms.
Results 160 SRC (median age 19.1 years; female=86 (54%); male=74 (46%)) were observed with a median (IQR) RTS duration of 34.0 (21.0–63.0) days. Median days to care access was different in the early (1; n SRC =77) and late (20; n SRC =83) groups, resulting in median (IQR) RTS duration of 26.0 (17.0–38.5) and 45.0 (27.5–84.5) days, respectively (p<0.001). Initial symptoms displayed a meaningful correlation with prognosis in this study (p<0.05), and female athletes (52 days (95% CI 42 to 101)) had longer recovery trajectories than male athletes (39 days (95% CI 31 to 65)) in the late access group (p<0.05).
Conclusions Olympic athletes in this cohort experienced an RTS time frame of about a month, partly due to limited access to multidisciplinary care and resources. Earlier access to care shortened the RTS delay. Greater initial symptoms and female sex in the late access group were meaningful modifiers of a longer RTS.
Data are available on reasonable request. Due to the confidential nature of the dataset, it will be shared through a controlled access repository and made available on specific and reasonable requests.
https://doi.org/10.1136/bjsports-2024-108211
Request permissions.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Most data regarding the impact of sport-related concussion (SRC) guidelines on return to sport (RTS) are derived from collegiate or recreational athletes. In these groups, time to RTS has steadily increased in the literature since 2005, coinciding with the evolution of RTS guidelines. However, current evidence suggests that earlier access to care may accelerate recovery and RTS time frames.
This study reports epidemiological data on the occurrence of SRC in athletes from several Summer and Winter Olympic sports with either early or late access to multidisciplinary care. We found the median time to RTS for Olympic athletes with an SRC was 34.0 days which is longer than that reported in other athletic groups such as professional or collegiate athletes. Time to RTS was reduced by prompt access to multidisciplinary care following SRC, and sex-influenced recovery in the late access group with female athletes having a longer RTS timeline. Greater initial symptoms, but not prior concussion history, were also associated with a longer time to RTS.
Considerable differences exist in access to care for athletes engaged in Olympic sports, which impact their recovery. In this cohort, several concussions occurred during international competitions where athletes are confronted with poor access to organised healthcare. Pathways for prompt access to multidisciplinary care should be considered by healthcare authorities, especially for athletes who travel internationally and may not have the guidance or financial resources to access recommended care.
After two decades of consensus statements, sport-related concussion (SRC) remains a high focus of research, with incidence ranging from 0.1 to 21.5 SRC per 1000 athlete exposures, varying according to age, sex, sport and level of competition. 1 2 Evidence-based guidelines have been proposed by experts to improve its identification and management, such as those from the Concussion in Sport Group. 3 Notably, they recommend specific strategies to improve SRC detection and monitoring such as immediate removal, 4 prompt access to healthcare providers, 5 evidence-based interventions 6 and multidisciplinary team approaches. 7 It is believed that these guidelines contribute to improving the early identification and management of athletes with an SRC, thereby potentially mitigating its long-term consequences.
Nevertheless, evidence regarding the impact of SRC guidelines implementation remains remarkably limited, especially within high-performance sport domains. In fact, most reported SRC data focus on adolescent student-athletes, collegiate and sometimes professional athletes in the USA but often neglect Olympians. 1 2 8–11 Athletes engaged in Olympic sports, often referred to as elite amateurs, are typically classified among the highest performers in elite sport, alongside professional athletes. 12 13 They train year-round and uniquely compete regularly on the international stage in sports that often lack professional leagues and rely on highly variable resources and facilities, mostly dependent on winning medals. 14 Unlike professional athletes, Olympians do not have access to large financial rewards. Although some Olympians work or study in addition to their intensive sports practice, they can devote more time to full-time sports practice compared with collegiate athletes. Competition calendars in Olympians differ from collegiate athletes, with periodic international competitions (eg, World Cups, World Championships) throughout the whole year rather than regular domestic competitions within a shorter season (eg, semester). Olympians outclass most collegiate athletes, and only the best collegiate athletes will have the chance to become Olympians and/or professionals. 12 13 15 In Canada, a primary reason for limited SRC data in Olympic sports is that the Canadian Olympic and Paralympic Sports Institute (COPSI) network only adopted official guidelines in 2018 to standardise care for athletes’ SRC nationwide. 16 17 The second reason could be the absence of a centralised medical structure and surveillance systems, identified as key factors contributing to the under-reporting and underdiagnosis of athletes with an SRC. 18
Among the available evidence on the evolution of SRC management, a 2023 systematic review and meta-analysis in athletic populations including children, adolescents and adults indicated that a full return to sport (RTS) could take up to a month but is estimated to require 19.8 days on average (15.4 days in adults), as opposed to the initial expectation of approximately 10.0 days based on studies published prior to 2005. 19 In comparison, studies focusing strictly on American collegiate athletes report median times to RTS of 16 days. 9 20 21 Notably, a recent study of military cadets reported an even longer return to duty times of 29.4 days on average, attributed to poorer access to care and fewer incentives to return to play compared with elite sports. 22 In addition, several modifiers have also been identified as influencing the time to RTS, such as the history of concussions, type of sport, sex, past medical problems (eg, preinjury modifiers), as well as the initial number of symptoms and their severity (eg, postinjury modifiers). 20 22 The evidence regarding the potential influence of sex on the time to RTS has yielded mixed findings in this area. 23–25 In fact, females are typically under-represented in SRC research, highlighting the need for additional studies that incorporate more balanced sample representation across sexes and control for known sources of bias. 26 Interestingly, a recent Concussion Assessment, Research and Education Consortium study, which included a high representation of concussed female athletes (615 out of 1071 patients), revealed no meaningful differences in RTS between females and males (13.5 and 11.8 days, respectively). 27 Importantly, findings in the sporting population suggested that earlier initiation of clinical care is linked to shorter recovery after concussion. 5 28 However, these factors affecting the time to RTS require a more thorough investigation, especially among athletes engaged in Olympic sports who may or may not have equal access to prompt, high-quality care.
Therefore, the primary objective of this study was to provide descriptive statistics among athletes with SRC engaged in both Summer and Winter Olympic sport programmes over a quadrennial, and to assess the influence of recommended guidelines of the COPSI network and the fifth International Consensus Conference on Concussion in Sport on the duration of RTS performance. 16 17 Building on available evidence, the international schedule constraints, variability in resources 14 and high-performance expectation among this elite population, 22 prolonged durations for RTS, compared with what is typically reported (eg, 16.0 or 15.4 days), were hypothesised in Olympians. 3 19 The secondary objective was to more specifically evaluate the impact of access to multidisciplinary care and injury modifiers on the time to RTS. Based on current evidence, 5 7 29 30 the hypothesis was formulated that athletes with earlier multidisciplinary access would experience a faster RTS. Regarding injury modifiers, it was expected that female and male athletes would show similar time to RTS despite presenting sex-specific characteristics of SRC. 31 The history of concussions, the severity of initial symptoms and the number of specialist consults were expected to be positively correlated to the time to RTS. 20 32
A total of 133 athletes (F=72; M=61; mean age±SD: 20.7±4.9 years old) who received medical care at the Institut national du sport du Québec, a COPSI training centre set up with a medical clinic, were included in this cohort study with retrospective analysis. They participated in 23 different Summer and Winter Olympic sports which were classified into six categories: team (soccer, water polo), middle distance/power (rowing, swimming), speed/strength (alpine skiing, para alpine skiing, short and long track speed skating), precision/skill-dependent (artistic swimming, diving, equestrian, figure skating, gymnastics, skateboard, synchronised skating, trampoline) and combat/weight-making (boxing, fencing, judo, para judo, karate, para taekwondo, wrestling) sports. 13 This sample consists of two distinct groups: (1) early access group in which athletes had access to a medical integrated support team of multidisciplinary experts within 7 days following their SRC and (2) late access group composed of athletes who had access to a medical integrated support team of multidisciplinary experts eight or more days following their SRC. 5 30 Inclusion criteria for the study were participation in a national or international-level sports programme 13 and having sustained at least one SRC diagnosed by an authorised healthcare practitioner (eg, physician and/or physiotherapist).
The institute clinic provides multidisciplinary services for care of patients with SRC including a broad range of recommended tests for concussion monitoring ( table 1 ). The typical pathway for the athletes consisted of an initial visit to either a sports medicine physician or their team sports therapist. A clinical diagnosis of SRC was then confirmed by a sports medicine physician, and referral for the required multidisciplinary assessments ensued based on the patient’s signs and symptoms. Rehabilitation progression was based on the evaluation of exercise tolerance, 33 priority to return to cognitive tasks and additional targeted support based on clinical findings of a cervical, visual or vestibular nature. 17 The expert team worked in an integrated manner with the athlete and their coaching staff for the rehabilitation phase, including regular round tables and ongoing communication. 34 For some athletes, access to recommended care was fee based, without a priori agreements with a third party payer (eg, National Sports Federation).
Main evaluations performed to guide the return to sport following sport-related concussion
Data were collected at the medical clinic using a standardised injury surveillance form based on International Olympic Committee guidelines. 35 All injury characteristics were extracted from the central injury database between 1 July 2018 and 31 July 2022. This period corresponds to a Winter Olympic sports quadrennial but also covers 3 years for Summer Olympic sports due to the postponing of the Tokyo 2020 Olympic Games. Therefore, the observation period includes a typical volume of competitions across sports and minimises differences in exposure based on major sports competition schedules. The information extracted from the database included: participant ID, sex, date of birth, sport, date of injury, type of injury, date of their visit at the clinic, clearance date of unrestricted RTS (eg, defined as step 6 of the RTS strategy with a return to normal gameplay including competitions), the number and type of specialist consults, mechanism of injury (eg, fall, hit), environment where the injury took place (eg, training, competition), history of concussions, history of modifiers (eg, previous head injury, migraines, learning disability, attention deficit disorder or attention deficit/hyperactivity disorder, depression, anxiety, psychotic disorder), as well as the number of symptoms and the total severity score from the first Sport Concussion Assessment Tool 5 (SCAT5) assessment following SRC. 17
Following a Shapiro-Wilk test, medians, IQR and non-parametric tests were used for the analyses because of the absence of normal distributions for all the variables in the dataset (all p<0.001). The skewness was introduced by the presence of individuals that required lengthy recovery periods. One participant was removed from the analysis because their time to consult with the multidisciplinary team was extremely delayed (>1 year).
Descriptive statistics were used to describe the participant’s demographics, SRC characteristics and risk factors in the total sample. Estimated incidences of SRC were also reported for seven resident sports at the institute for which it was possible to quantify a detailed estimate of training volume based on the annual number of training and competition hours as well as the number of athletes in each sport.
To assess if access to multidisciplinary care modified the time to RTS, we compared time to RTS between early and late access groups using a method based on median differences described elsewhere. 36 Wilcoxon rank sum tests were also performed to make between-group comparisons on single variables of age, time to first consult, the number of specialists consulted and medical visits. Fisher’s exact tests were used to compare count data between groups on variables of sex, history of concussion, time since the previous concussion, presence of injury modifiers, environment and mechanism of injury. Bonferroni corrections were applied for multiple comparisons in case of meaningful differences.
To assess if injury modifiers modified time to RTS in the total sample, we compared time to RTS between sexes, history of concussions, time since previous concussion or other injury modifiers using a method based on median differences described elsewhere. 36 Kaplan-Meier curves were drawn to illustrate time to RTS differences between sexes (origin and start time: date of injury; end time: clearance date of unrestricted RTS). Trajectories were then assessed for statistical differences using Cox proportional hazards model. Wilcoxon rank sum tests were employed for comparing the total number of symptoms and severity scores on the SCAT5. The association of multilevel variables on return to play duration was evaluated in the total sample with Kruskal-Wallis rank tests for environment, mechanism of injury, history of concussions and time since previous concussion. For all subsequent analyses of correlations between SCAT5 results and secondary variables, only data obtained from SCAT5 assessments within the acute phase of injury (≤72 hours) were considered (n=65 SRC episodes in the early access group). 37 Spearman rank correlations were estimated between RTS duration, history of concussions, number of specialist consults and total number of SCAT5 symptoms or total symptom severity. All statistical tests were performed using RStudio (R V.4.1.0, The R Foundation for Statistical Computing). The significance level was set to p<0.05.
The study population is representative of the Canadian athletic population in terms of age, gender, demographics and includes a balanced representation of female and male athletes. The study team consists of investigators from different disciplines and countries, but with a predominantly white composition and under-representation of other ethnic groups. Our study population encompasses data from the Institut national du sport du Québec, covering individuals of all genders, ethnicities and geographical regions across Canada.
The patients or the public were not involved in the design, conduct, reporting or dissemination plans of our research.
During the 4-year period covered by this retrospective chart review, a total of 160 SRC episodes were recorded in 132 athletes with a median (IQR) age of 19.1 (17.8–22.2) years old ( table 2 ). 13 female and 10 male athletes had multiple SRC episodes during this time. The sample had a relatively balanced number of females (53.8%) and males (46.2%) with SRC included. 60% of the sample reported a history of concussion, with 35.0% reporting having experienced more than two episodes. However, most of these concussions had occurred more than 1 year before the SRC for which they were being treated. Within this sample, 33.1% of participants reported a history of injury modifiers. Importantly, the median (IQR) time to first clinic consult was 10.0 (1.0–20.0) days and the median (IQR) time to RTS was 34.0 (21.0–63.0) days in this sample ( table 3 ). The majority of SRCs occurred during training (56.3%) rather than competition (33.1%) and were mainly due to a fall (63.7%) or a hit (31.3%). The median (IQR) number of follow-up consultations and specialists consulted after the SRC were, respectively, 9 (5.0–14.3) and 3 (2.0–4.0).
Participants demographics
Sport-related concussion characteristics
Among seven sports of the total sample (n=89 SRC), the estimated incidence of athletes with SRC was highest in short-track speed skating (0.47/1000 hours; 95% CI 0.3 to 0.6), and lower in boxing, trampoline, water polo, judo, artistic swimming, and diving (0.24 (95% CI 0.0 to 0.5), 0.16 (95% CI 0.0 to 0.5), 0.13 (95% CI 0.1 to 0.2), 0.11 (95% CI 0.1 to 0.2), 0.09 (95% CI 0.0 to 0.2) and 0.06 (95% CI 0.0 to 0.1)/1000, respectively ( online supplemental material ). Furthermore, most athletes sustained an SRC in training (66.5%; 95% CI 41.0 to 92.0) rather than competition (26.0%; 95% CI 0.0 to 55.0) except for judo athletes (20.0% (95% CI 4.1 to 62.0) and 80.0% (95% CI 38.0 to 96.0), respectively). Falls were the most common injury mechanism in speed skating, trampoline and judo while hits were the most common injury mechanism in boxing, water polo, artistic swimming and diving.
Access to care.
The median difference in time to RTS was 19 days (95% CI 9.3 to 28.7; p<0.001) between the early (26 (IQR 17.0–38.5) days) and late (45 (IQR 27.5–84.5) days) access groups ( table 3 ; figure 1 ). Importantly, the distribution of SRC environments was different between both groups (p=0.008). The post hoc analysis demonstrated a meaningful difference in the distribution of SRC in training and competition environments between groups (p=0.029) but not for the other comparisons. There was a meaningful difference between the groups in time to first consult (p<0.001; 95% CI −23.0 to −15.0), but no meaningful differences between groups in median age (p=0.176; 95% CI −0.3 to 1.6), sex distribution (p=0.341; 95% CI 0.7 to 2.8), concussion history (p=0.210), time since last concussion (p=0.866), mechanisms of SRC (p=0.412), the presence of modifiers (p=0.313; 95% CI 0.3 to 1.4) and the number of consulted specialists (p=0.368; 95% CI −5.4 to 1.0) or medical visits (p=0.162; 95% CI −1.0 to 3.0).
Time to return to sport following sport-related concussion as a function of group’s access to care and sex. Outliers: below=Q1−1.5×IQR; above=Q3+1.5×IQR.
The median difference in time to RTS was 6.5 days (95% CI −19.3 to 5.3; p=0.263; figure 1 ) between female (37.5 (IQR 22.0–65.3) days) and male (31.0 (IQR 20.0–48.0) days) athletes. Survival analyses highlighted an increased hazard of longer recovery trajectory in female compared with male athletes (HR 1.4; 95% CI 1.4 to 0.7; p=0.052; figure 2A ), which was mainly driven by the late (HR 1.8; 95% CI 1.8 to 0.6; p=0.019; figure 2C ) rather than the early (HR 1.1; 95% CI 1.1 to 0.9; p=0.700; figure 2B ) access group. Interestingly, a greater number of female athletes (n=15) required longer than 100 days for RTS as opposed to the male athletes (n=6). There were no meaningful differences between sexes for the total number of symptoms recorded on the SCAT5 (p=0.539; 95% CI −1.0 to 2.0) nor the total symptoms total severity score (p=0.989; 95% CI −5.0 to 5.0).
Time analysis of sex differences in the time to return to sport following sport-related concussion in the (A) total sample, as well as (B) early, and (C) late groups using survival curves with 95% confidence bands and tables of time-specific number of patients at risk (censoring proportion: 0%).
SRC modifiers are presented in table 2 , and their influence on RTP is shown in table 4 . The median difference in time to RTS was 1.5 days (95% CI −10.6 to 13.6; p=0.807) between athletes with none and one episode of previous concussion, was 3.5 days (95% CI −13.9 to 19.9; p=0.728) between athletes with none and two or more episodes of previous concussion, and was 2 days (95% CI −12.4 to 15.4; p=0.832) between athletes with one and two or more episodes of previous concussion. The history of concussions (none, one, two or more) had no meaningful impact on the time to RTS (p=0.471). The median difference in time to RTS was 4.5 days (95% CI −21.0 to 30.0; p=0.729) between athletes with none and one episode of concussion in the previous year, was 2 days (95% CI −10.0 to 14.0; p=0.744) between athletes with none and one episode of concussion more than 1 year ago, and was 2.5 days (95% CI −27.7 to 22.7; p=0.846) between athletes with an episode of concussion in the previous year and more than 1 year ago. Time since the most recent concussion did not change the time to RTS (p=0.740). The longest time to RTS was observed in the late access group in which athletes had a concussion in the previous year, with a very large spread of durations (65.0 (IQR 33.0–116.5) days). The median difference in time to RTS was 3 days (95% CI −13.1 to 7.1; p=0.561) between athletes with and without other injury modifiers. The history of other injury modifiers had no meaningful influence on the time to RTS (95% CI −6.0 to 11.0; p=0.579).
Preinjury modifiers of time to return to sport following SRC
Positive associations were observed between the time to RTS and the number of initial symptoms (r=0.3; p=0.010; 95% CI 0.1 to 0.5) or initial severity score (r=0.3; p=0.008; 95% CI 0.1 to 0.5) from the SCAT5. The associations were not meaningful between the number of specialist consultations and the initial number of symptoms (r=−0.1; p=0.633; 95% CI −0.3 to 0.2) or initial severity score (r=−0.1; p=0.432; 95% CI −0.3 to 0.2). Anecdotally, most reported symptoms following SRC were ‘headache’ (86.2%) and ‘pressure in the head’ (80.0%), followed by ‘fatigue’ (72.3%), ‘neck pain’ (70.8%) and ‘not feeling right’ (67.7%; online supplemental material ).
This study is the first to report descriptive data on athletes with SRC collected across several sports during an Olympic quadrennial, including athletes who received the most recent evidence-based care at the time of data collection. Primarily, results indicate that the time to RTS in athletes engaged in Summer and Winter Olympic sports may require a median (IQR) of 34.0 (21.0–63.0) days. Importantly, findings demonstrated that athletes with earlier (≤7 days) access to multidisciplinary concussion care showed faster RTS compared with those with late access. Time to RTS exhibited large variability where sex had a meaningful influence on the recovery pathway in the late access group. Initial symptoms, but not history of concussion, were correlated with prognosis in this sample. The main reported symptoms were consistent with previous studies. 38 39
This study provides descriptive data on the impact of SRC monitoring programmes on recovery in elite athletes engaged in Olympic sports. As hypothesised, the median time to RTS found in this study (eg, 34.0 days) was about three times longer than those found in reports from before 2005, and 2 weeks longer than the typical median values (eg, 19.8 days) recently reported in athletic levels including youth (high heterogeneity, I 2 =99.3%). 19 These durations were also twice as long as the median unrestricted time to RTS observed among American collegiate athletes, which averages around 16 days. 9 20 21 However, they were more closely aligned with findings from collegiate athletes with slow recovery (eg, 34.7 days) and evidence from military cadets with poor access where return to duty duration was 29.4 days. 8 22 Several reasons could explain such extended time to RTS, but the most likely seems to be related to the diversity in access among these sports to multidisciplinary services (eg, 10.0 median days (1–20)), well beyond the delays experienced by collegiate athletes, for example (eg, 0.0 median days (0–2)). 40 In the total sample, the delays to first consult with the multidisciplinary clinic were notably mediated by the group with late access, whose athletes had more SRC during international competition. One of the issues for athletes engaged in Olympic sports is that they travel abroad year-round for competitions, in contrast with collegiate athletes who compete domestically. These circumstances likely make access to quality care very variable and make the follow-up of care less centralised. Also, access to resources among these sports is highly variable (eg, medal-dependant), 14 and at the discretion of the sport’s leadership (eg, sport federation), who may decide to prioritise more or fewer resources to concussion management considering the relatively low incidence of this injury. Another explanation for the longer recovery times in these athletes could be the lack of financial incentives to return to play faster, which are less prevalent among Olympic sports compared with professionals. However, the stakes of performance and return to play are still very high among these athletes.
Additionally, it is plausible that studies vary their outcome with shifting operational definitions such as resolution of symptoms, return to activities, graduated return to play or unrestricted RTS. 19 40 It is understood that resolution of symptoms may occur much earlier than return to preinjury performance levels. Finally, an aspect that has been little studied to date is the influence of the sport’s demands on the RTS. For example, acrobatic sports requiring precision/technical skills such as figure skating, trampoline and diving, which involve high visuospatial and vestibular demands, 41 might require more time to recover or elicit symptoms for longer times. Anecdotally, athletes who experienced a long time to RTS (>100 days) were mostly from precision/skill-dependent sports in this sample. The sports demand should be further considered as an injury modifier. More epidemiological reports that consider the latest guidelines are therefore necessary to gain a better understanding of the true time to RTS and impact following SRC in Olympians.
In this study, athletes who obtained early access to multidisciplinary care after SRC recovered faster than those with late access to multidisciplinary care. This result aligns with findings showing that delayed access to a healthcare practitioner delays recovery, 19 including previous evidence in a sample of patients from a sports medicine clinic (ages 12–22), indicating that the group with a delayed first clinical visit (eg, 8–20 days) was associated with a 5.8 times increased likelihood of a recovery longer than 30 days. 5 Prompt multidisciplinary approach for patients with SRC is suggested to yield greater effectiveness over usual care, 3 6 17 which is currently evaluated under randomised controlled trial. 42 Notably, early physical exercise and prescribed exercise (eg, 48 hours postinjury) are effective in improving recovery compared with strict rest or stretching. 43 44 In fact, preclinical and clinical studies have shown that exercise has the potential to improve neurotransmission, neuroplasticity and cerebral blood flow which supports that the physically trained brain enhanced recovery. 45 46 Prompt access to specialised healthcare professionals can be challenging in some contexts (eg, during international travel), and the cost of accessing medical care privately may prove further prohibitive. This barrier to recovery should be a priority for stakeholders in Olympic sports and given more consideration by health authorities.
The estimated incidences of SRC were in the lower range compared with what is reported in other elite sport populations. 1 2 However, the burden of injury remained high for these sports, and the financial resources as well as expertise required to facilitate athletes’ rehabilitation was considerable (median number of consultations: 9.0). Notably, the current standard of public healthcare in Canada does not subsidise the level of support recommended following SRC as first-line care, and the financial subsidisation of this recommended care within each federation is highly dependent on the available funding, varying significantly between sports. 14 Therefore, the ongoing efforts to improve education, prevention and early recognition, modification of rules to make the environments safer and multidisciplinary care access for athletes remain crucial. 7
This unique study provides multisport characteristics following the evolution of concussion guidelines in Summer and Winter Olympic sports in North America. Notably, it features a balance between the number of female and male athletes, allowing the analysis of sex differences. 23 26 In a previous review of 171 studies informing consensus statements, samples were mostly composed of more than 80% of male participants, and more than 40% of these studies did not include female participants at all. 26 This study also included multiple non-traditional sports typically not encompassed in SRC research, feature previously identified as a key requirement of future epidemiological research. 47
However, it must be acknowledged that potential confounding factors could influence the results. For example, the number of SRC detected during the study period does not account for potentially unreported concussions. Nevertheless, this figure should be minimal because these athletes are supervised both in training and in competition by medical staff. Next, the sport types were heterogeneous, with inconsistent risk for head impacts or inconsistent sport demand which might have an influence on recovery. Furthermore, the number of participants or sex in each sport was not evenly distributed, with short-track speed skaters representing a large portion of the overall sample (32.5%), for example. Additionally, the number of participants with specific modifiers was too small in the current sample to conclude whether the presence of precise characteristics (eg, history of concussion) impacted the time to RTS. Also, the group with late access was more likely to consist of athletes who sought specialised care for persistent symptoms. These complex cases are often expected to require additional time to recover. 48 Furthermore, athletes in the late group may have sought support outside of the institute medical clinic, without a coordinated multidisciplinary approach. Therefore, the estimation of clinical consultations was tentative for this group and may represent a potential confounding factor in this study.
This is the first study to provide evidence of the prevalence of athletes with SRC and modifiers of recovery in both female and male elite-level athletes across a variety of Summer and Winter Olympic sports. There was a high variability in access to care in this group, and the median (IQR) time to RTS following SRC was 34.0 (21.0–63.0) days. Athletes with earlier access to multidisciplinary care took nearly half the time to RTS compared with those with late access. Sex had a meaningful influence on the recovery pathway in the late access group. Initial symptom number and severity score but not history of concussion were meaningful modifiers of recovery. Injury surveillance programmes targeting national sport organisations should be prioritised to help evaluate the efficacy of recommended injury monitoring programmes and to help athletes engaged in Olympic sports who travel a lot internationally have better access to care. 35 49
Patient consent for publication.
Not applicable.
This study involves human participants and was approved by the ethics board of Université de Montréal (certificate #2023-4052). Participants gave informed consent to participate in the study before taking part.
The authors would like to thank the members of the concussion interdisciplinary clinic of the Institut national du sport du Québec for collecting the data and for their unconditional support to the athletes.
Supplementary data.
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
X @ThomasRomeas
Correction notice This article has been corrected since it published Online First. The ORCID details have been added for Dr Croteau.
Contributors TR, FC and SL were involved in planning, conducting and reporting the work. François Bieuzen and Magdalena Wojtowicz critically reviewed the manuscript. TR is guarantor.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
A method utilizing an embedded sensing system to determine the dynamic load is proposed to address the problem of not being able to directly obtain the dynamic load time history of a crawler driving structure in the harsh underground working environment of a coal mine roadheader robot. A crawler driving structure and its embedded sensing system are designed. A rigid–flexible coupling simulation model of the roadheader robot is established, and the dynamic load time history parameters of the crawler obtained from the simulation and test data are compared and analyzed. Results show that the load fluctuation of the tested track plate at the idler and sprocket is significant. By contrast, the fluctuation of the free segment is minimal. The load fluctuation range of the support segment of the hard road is −5–15 MPa, and that of the soft sand road is −10–25 MPa. Moreover, the track plate exhibits noticeable warping and winding phenomenon relative to the road wheel on the soft sand road. The changing trend of the crawler dynamic load time history obtained from simulation and test is relatively consistent. This study provides a reference for the crawler driving structure’s structural optimization and reliability research.
This is a preview of subscription content, log in via an institution to check access.
Subscribe and save.
Price includes VAT (Russian Federation)
Instant access to the full article PDF.
Rent this article via DeepDyve
Institutional subscriptions
Working tension
Tension of the free segment
Tension of the working segment
Dynamic forces by the left side of the i th road wheel
Dynamic forces by the right sides of the i th road wheel
Supporting force on the ground facing the i th road wheel
Vertical component of the supporting force of the vehicle body on the i th road wheel
Sprocket torque
Young’s modulus of the track
Radius of the dividing circle of the sprocket
Diameter of the ith road wheel
Diameters of the idler
Diameters of the sprocket
Track overhang
Relative vertical of the track
Track length
Thickness of the track
Angle between F Ti and the horizontal road surface
Angle between F T(i+1) and the horizontal road surface
Radius of the ith road wheel
Rotational inertia of the i th road wheel
Rotational angular velocity of the i th road wheel
Friction coefficient between the track shoe and the ground
Mass of the i th road wheel
Stiffness index of contact
Damping index of contact
Dent index of contact
Normal contact
Contact stiffness coefficient
Damping coefficient
Contact penetration depth
Track mass per unit length
Relative speed of the track link relative to the vehicle
Cross-sectional area of deformation of tested track plate
Dynamic load of the tested track plate in the free segment
Dynamic load of the tested track plate in the working segment
Dynamic load between the i th road wheel and the (i+1) th road wheel
Bend stress when the tested track plate wrapped around the i th road wheel
Bend stress when the tested track plate wrapped around the idler
Bend stress when the tested track plate wrapped around the sprocket
H. Zhang, P. Kang and Y. Song, Dynamic modeling method and experiment of sliding track walking system, Journal of Vibration, Measurement & Diagnosis , 35(1) (2015) 70–75.
Google Scholar
H. Zhang, X. K. Zhang and T. Shi, Analysis on dynamics features and fatigue life of crawler walking mechanism applied in continuous miner, Coal Science and Technology , 44(11) (2016) 110–115.
C. W. Wang, H. W. Ma and X. S. Xue, Multi-body dynamics modeling and obstacle surmounting simulation of tracked inspection robot in coal mine, Journal of Xi’an University of Science and Technology , 40(5) (2020) 790–796.
Z. R. Chen, D. M. Xue and G. Q. Wang, Simulation and optimization of the tracked chassis performance of electric shovel based on DEM-MBD, Powder Technology , 390 (2021) 428–441.
Article Google Scholar
S. Frimpong and M. Thiruvengadam, Rigid multi-body kinematics of shovel crawler-formation interactions, International Journal of Mining, Reclamation and Environment , 30(4) (2016) 347–369.
P. Wang, H. Yu and X. Rui, Transversal vibration analysis of the upper span of nonlinear closed-loop track systems, Applied Mathematical Modeling , 78 (2020) 249–267.
Article MathSciNet Google Scholar
Y. Liu, T. Zhang and N. Xie, Multi-body dynamic modeling and verification of small agricultural crawler chassis, Transactions of the Chinese Society of Agricultural Engineering , 35 (7) 2019 39–46.
W. D. Wang, Z. Y. Yan and Z. J. Du, Experimental study of a tracked mobile robot’s mobility performance, Journal of Terramechanics , 77 (2018) 75–84.
N. Ö. Mehmet, K. Varlık and Y. SÜ, A new contact & slip model for tracked vehicle transient dynamics on hard ground, Journal of Terramechanics , 73 (2017) 3–23.
K. Hu, W. Y. Zhang and K. Li, Multi-body dynamics modeling and experiment of triangular tracked chassis with high ground clearance, Transactions of the Chinese Society for Agricultural Machinery , 52(7) (2021) 386–394.
B. F. Hao, H. Y. Wang and Q. Rui, Dynamics modeling and model test verification of tank multibody systems, China Mechanical Engineering , 29(4) (2018) 429–433.
L. Q. Chen, P. P. Wang and P. Zhang, Performance analysis and test of a maize inter-row self-propelled thermal fogger chassis, International Journal of Agricultural and Biological Engineering , 11 (2018) 100–107.
R. Bai, D. X. Pei and R. Xie, Research on the embedded stress test system of vehicle driving wheel, Chinese Journal of Electron Devices , 39(3) (2016) 746–749.
P. Kang, Remote dynamic testing technology of bolt drilling vehicle walking system, Colliery Mechanical & Electrical Technol , 40(3) (2019) 36–38.
Z. H. Zhang, H. Zhang and Y. Chen, Load identification method of track driving system based on genetic neural network, Journal of Vibration and Shock , 41(3) (2022) 54–61.
W. W. Liu, K. Cheng and J. Wang, Failure analysis of the rubber track of a tracked transporter, Advances in Mechanical Engineering , 10(7) (2018) 1–8.
H. Y. Zhao, G. Q. Wang and H. T. Wang, Fatigue life analysis of crawler chain link of excavator, Engineering Failure Analysis , 79 (2017) 737–748.
W. W. Liu, Research on fatigue and initial track tension optimization of the track for an all-terrain articulated tracked vehicle. Ph.D. Thesis , Jilin University, China (2021).
X. J. Jiao, J. W. Zhang and B. B. Peng, RecurDyn Multibody System Optimization Simulation Technology , 1st. Tsinghua University Press, Beijing, China (2010).
Download references
This work is supported by the National Natural Science Foundation of China (grant number 52075355) and Shanxi Provincial Key Research and Development Project (grant number 202202100401012).
Authors and affiliations.
School of Mechanical Engineering, Taiyuan University of Science and Technology, Taiyuan, Shanxi, People’s Republic of China
Yang Liu, Hong Zhang, Xiaobing Chen & Guozhu Yin
Taiyuan Research Institute Company Limited, China Coal Technology and Engineering Group, Taiyuan, Shanxi, People’s Republic of China
You can also search for this author in PubMed Google Scholar
Correspondence to Hong Zhang .
Yang Liu is currently a master’s candidate student in Mechanical Engineering at the Taiyuan University of Science and Technology, Taiyuan, China. His research interests include mechanical condition health monitoring and intelligent maintenance.
Hong Zhang is a Professor at Taiyuan University of Science and Technology, Taiyuan, China. His research interests include machinery and special vehicle dynamics, coal mining equipment development, fluid transmission and control, dynamic monitoring, and fault diagnosis.
Yang Song is currently a mechanical engineer at Taiyuan Research Institute Company Limited, China Coal Technology and Engineering Group. His research interests include continuous carrier equipment and its system theory.
Xiaobing Chen is currently a master’s candidate student in Mechanical Engineering at the Taiyuan University of Science and Technology, Taiyuan, China. His research interests include crawler dynamics and vibration control.
Guozhu Yin is currently a master candidate student in Mechanical Engineering at the Taiyuan University of Science and Technology, Taiyuan, China. His research interests include vibration testing and fault diagnosis.
Reprints and permissions
Liu, Y., Zhang, H., Song, Y. et al. Dynamic load acquisition method for a crawler driving structure of a roadheader robot under random road. J Mech Sci Technol (2024). https://doi.org/10.1007/s12206-024-0814-5
Download citation
Received : 31 March 2024
Revised : 20 May 2024
Accepted : 25 May 2024
Published : 05 September 2024
DOI : https://doi.org/10.1007/s12206-024-0814-5
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
IMAGES
VIDEO
COMMENTS
A Practical Guide to Writing Quantitative and Qualitative ...
The methodology section or methods section tells you how the author (s) went about doing their research. It should let you know a) what method they used to gather data (survey, interviews, experiments, etc.), why they chose this method, and what the limitations are to this method. The methodology section should be detailed enough that another ...
Step 1: Explain your methodological approach. Step 2: Describe your data collection methods. Step 3: Describe your analysis method. Step 4: Evaluate and justify the methodological choices you made. Tips for writing a strong methodology chapter. Other interesting articles.
What is Research Methodology? Definition, Types, and ...
Research methods are specific procedures for collecting and analyzing data. Developing your research methods is an integral part of your research design. When planning your methods, there are two key decisions you will make. First, decide how you will collect data. Your methods depend on what type of data you need to answer your research question:
Provide the rationality behind your chosen approach. Based on logic and reason, let your readers know why you have chosen said research methodologies. Additionally, you have to build strong arguments supporting why your chosen research method is the best way to achieve the desired outcome. 3. Explain your mechanism.
What Is Research Methodology? Definition + Examples
Your Methods Section contextualizes the results of your study, giving editors, reviewers and readers alike the information they need to understand and interpret your work. Your methods are key to establishing the credibility of your study, along with your data and the results themselves. A complete methods section should provide enough detail for a skilled researcher to replicate your process ...
A method article is a medium length peer-reviewed, research-focused article type that aims to answer a specific question. It also describes an advancement or development of current methodological approaches and research procedures (akin to a research article), following the standard layout for research articles.
About Research Methods. This guide provides an overview of research methods, how to choose and use them, and supports and resources at UC Berkeley. As Patten and Newhart note in the book Understanding Research Methods, "Research methods are the building blocks of the scientific enterprise. They are the "how" for building systematic knowledge.
Even though methodological studies can be conducted on qualitative or mixed methods research, this paper focuses on and draws examples exclusively from quantitative research. The objectives of this paper are to provide some insights on how to conduct methodological studies so that there is greater consistency between the research questions ...
A research methodology encompasses the way in which you intend to carry out your research. This includes how you plan to tackle things like collection methods, statistical analysis, participant observations, and more. You can think of your research methodology as being a formula. One part will be how you plan on putting your research into ...
The typical research paper is a highly codified rhetorical form [1, 2]. Knowledge of the rules—some explicit, others implied—goes a long way toward writing a paper that will get accepted in a peer-reviewed journal. Primacy of the research question. A good research paper addresses a specific research question.
SCIENTIFIC METHODOLOGY AND ITS COMPONENTS. Methodologyin science refers to the diverse prin- ciples, procedures, and practices that govern empiri- cal research. It is useful to distinguish five major components to convey the scope of the topics and to organize the subject matter. 1.
The Methods section of a research article includes an explanation of the procedures used to conduct the experiment. For authors of scientific research papers, the objective is to present their findings clearly and concisely and to provide enough information so that the experiment can be duplicated. Research articles contain very specific ...
Another option could be to focus on the research method or findings, and a third option is to conduct the review in stages by reading abstracts first and making selections and then reading full-text articles later, before making the final selection. Once this is done and the initial articles (or other relevant literature) have been collected ...
The methods section should describe what was done to answer the research question, describe how it was done, justify the experimental design, and explain how the results were analyzed. Scientific writing is direct and orderly. Therefore, the methods section structure should: describe the materials used in the study, explain how the materials ...
Background Overviews of methods are potentially useful means to increase clarity and enhance collective understanding of specific methods topics that may be characterized by ambiguity, inconsistency, or a lack of comprehensiveness. This type of review represents a distinct literature synthesis method, although to date, its methodology remains relatively undeveloped despite several aspects that ...
A tutorial on methodological studies: the what, when, how and ...
Despite the included journals indicating openness to articles that apply any research methods. This finding may be due to qualitative research still being seen as a new method (Burman and Whelan, 2011) or reviewers' standards being higher for qualitative studies (Bluhm et al., 2011). Future research is encouraged into the possible biasness in ...
A case study is one of the most commonly used methodologies of social research. This article attempts to look into the various dimensions of a case study research strategy, the different epistemological strands which determine the particular case study type and approach adopted in the field, discusses the factors which can enhance the effectiveness of a case study research, and the debate ...
Qualitative research methods. Each of the research approaches involve using one or more data collection methods.These are some of the most common qualitative methods: Observations: recording what you have seen, heard, or encountered in detailed field notes. Interviews: personally asking people questions in one-on-one conversations. Focus groups: asking questions and generating discussion among ...
Study design. The critical review method described by Grant and Booth (Citation 2009) was used, which is appropriate for the assessment of research quality, and is used for literature analysis to inform research and practice.This type of review goes beyond the mapping and description of scoping or rapid reviews, to include "analysis and conceptual innovation" (Grant & Booth, Citation 2009 ...
The following research methods were used in writing the article: analysis of literature on the problem, our own experience in teaching at the university. The result of the article is the ...
The impact of environmental disasters on refugees' health is an immensely understudied field of research. Applying a mixed-methods approach, we exemplified how such links can be studied, overcoming some of the current data limitations. Despite the limited scope of our study, we highlighted specific health risks faced by refugees in the MENA ...
With interpretability, robustness and accuracy provided by ST-GEARS, we anticipate its applications and extension in various areas of biological and medical research. We believe that our method ...
Small Methods. Early View 2400654. Research Article. Open Access. Strain Field Around Individual Dislocations Controls Failure. ... The full text of this article hosted at iucr.org is unavailable due to technical difficulties. Log in to Wiley Online Library. Email or Customer ID. Password.
Methods. In a retrospective study, we analyzed the electronic documentation of patients hospitalized for at least 48 h in a general PICU who received at least two different drugs within a 24-h interval. ... That could lead to information bias, as the documentation was not primarily compiled to answer research questions. Consequently, using the ...
Objectives This cohort study reported descriptive statistics in athletes engaged in Summer and Winter Olympic sports who sustained a sport-related concussion (SRC) and assessed the impact of access to multidisciplinary care and injury modifiers on recovery. Methods 133 athletes formed two subgroups treated in a Canadian sport institute medical clinic: earlier (≤7 days) and late (≥8 days ...
A method utilizing an embedded sensing system to determine the dynamic load is proposed to address the problem of not being able to directly obtain the dynamic load time history of a crawler driving structure in the harsh underground working environment of a coal mine roadheader robot. A crawler driving structure and its embedded sensing system are designed. A rigid-flexible coupling ...